Inactivation of human liver cytochrome P-450 by the drug methoxsalen and other psoralen derivatives
- PMID: 3494453
- DOI: 10.1016/0006-2952(87)90190-0
Inactivation of human liver cytochrome P-450 by the drug methoxsalen and other psoralen derivatives
Abstract
The effects of psoralen derivatives on cytochrome P-450 have been studied in human liver microsomes. CO-binding cytochrome P-450 was decreased by 33% after 10 min of incubation with 1.5 mM EDTA, an NADPH-regenerating system and 20 microM methoxsalen (8-methoxypsoralen). No destruction of cytochrome P-450 was observed when either NADPH or methoxsalen was omitted. A similar (27%) decrease in CO-binding required a 100-times higher concentration of allylisopropylacetamide (2 mM). The activities of 7-ethoxycoumarin deethylase and benzo(a)pyrene hydroxylase were decreased by about 50% in the presence of 12.5 microM methoxsalen. At this low concentration, neither cimetidine nor SKF 525-A or piperonyl butoxide had any significant inhibitory effect. Monooxygenase activities were also decreased in the presence of 12.5 microM bergapten (5-methoxypsoralen) or 12.5 microM psoralen, but not with 12.5 microM trioxsalen (trimethylpsoralen). CO-binding cytochrome P-450 was not decreased after 10 min of incubation with 1.5 mM EDTA, an NADPH-regenerating system and 20 microM trioxsalen. We conclude that methoxsalen is an extremely potent suicide inhibitor of cytochrome P-450 in human liver microsomes. Bergapten and psoralen are also inhibitory whereas trioxsalen has little effects. In the latter derivative, a methyl group is attached on the furan ring and may hinder its metabolic activation and the inactivation of cytochrome P-450.
Similar articles
-
Inactivation and induction of cytochrome P-450 by various psoralen derivatives in rats.J Pharmacol Exp Ther. 1986 Aug;238(2):685-92. J Pharmacol Exp Ther. 1986. PMID: 3735138
-
Inactivation of cytochrome P-450 by the drug methoxsalen.J Pharmacol Exp Ther. 1986 Jan;236(1):237-47. J Pharmacol Exp Ther. 1986. PMID: 3941395
-
Cinnamic acid 4-hydroxylase mechanism-based inactivation by psoralen derivatives: cloning and characterization of a C4H from a psoralen producing plant-Ruta graveolens-exhibiting low sensitivity to psoralen inactivation.Arch Biochem Biophys. 2004 Feb 1;422(1):71-80. doi: 10.1016/j.abb.2003.12.013. Arch Biochem Biophys. 2004. PMID: 14725859
-
Clinical pharmacokinetics of methoxsalen and other psoralens.Clin Pharmacokinet. 1986 Jan-Feb;11(1):62-75. doi: 10.2165/00003088-198611010-00004. Clin Pharmacokinet. 1986. PMID: 3512141 Review.
-
Chemical structure of psoralen-nucleic acid photoadducts.Biochimie. 1985 Mar-Apr;67(3-4):317-25. doi: 10.1016/s0300-9084(85)80074-2. Biochimie. 1985. PMID: 3899186 Review. No abstract available.
Cited by
-
Prediction of herb-drug interactions involving consumption of furanocoumarin-mixtures and cytochrome P450 1A2-mediated caffeine metabolism inhibition in humans.Saudi Pharm J. 2023 Mar;31(3):444-452. doi: 10.1016/j.jsps.2023.01.011. Epub 2023 Feb 1. Saudi Pharm J. 2023. PMID: 37026048 Free PMC article.
-
Therapeutic Effects of Coumarins with Different Substitution Patterns.Molecules. 2023 Mar 6;28(5):2413. doi: 10.3390/molecules28052413. Molecules. 2023. PMID: 36903660 Free PMC article. Review.
-
Inhibition of Caffeine Metabolism by Apiaceous and Rutaceae Families of Plant Products in Humans: In Vivo and In Vitro Studies.Front Pharmacol. 2021 Apr 29;12:641090. doi: 10.3389/fphar.2021.641090. eCollection 2021. Front Pharmacol. 2021. PMID: 33995046 Free PMC article.
-
Differences in xanthotoxin metabolites in seven mammalian liver microsomes.Exp Ther Med. 2020 Oct;20(4):3846-3852. doi: 10.3892/etm.2020.9098. Epub 2020 Aug 5. Exp Ther Med. 2020. PMID: 32855735 Free PMC article.
-
Coumarins as Modulators of the Keap1/Nrf2/ARE Signaling Pathway.Oxid Med Cell Longev. 2020 Apr 22;2020:1675957. doi: 10.1155/2020/1675957. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32377290 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources